BBA
INM icon

Baader Bank Aktiengesellschaft’s InMed Pharmaceuticals INM Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio INM Stock Details INM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,131
Closed -$3.84K – 435
2024
Q3 		$3.84K Buy
+1,131
New +$5.76K ﹤0.01% 423

Other funds holding INM

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AWM
AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Baader Bank Aktiengesellschaft's INM Position: Q4 2024 in Review

Baader Bank Aktiengesellschaft sold out of InMed Pharmaceuticals (INM) in Q4 2024, closing a stake of 1,131 shares — an estimated $3.84K sold.

Baader Bank Aktiengesellschaft first reported a position in INM in Q3 2024 and held it in 1 quarter. The position peaked at $3.84K in Q3 2024. 5 funds tracked by Wall St. Rank hold INM as of Q4 2024.

  • Baader Bank Aktiengesellschaft reported no remaining InMed Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 1,131 InMed Pharmaceuticals shares in Q4 2024, an estimated $3.84K.
  • Baader Bank Aktiengesellschaft first reported a position in InMed Pharmaceuticals in Q3 2024 and held it in 1 quarter.
  • Baader Bank Aktiengesellschaft's InMed Pharmaceuticals position peaked at $3.84K in Q3 2024.
  • 5 funds tracked by Wall St. Rank held InMed Pharmaceuticals as of Q4 2024.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q4 2024, filed 23 Jan 2025.